drugset / Trial / NCT01114893
Travoprost Five Day Posology Study
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of three concentrations of travoprost ophthalmic solution (Groups A, B and C) administered eight times daily.
Timeline
- Start
- 2010-04
- Primary completion
- 2010-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Travoprost | Other / unclassified | 0.004 % | Topical |